Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

EMD Millipore Wins R&D Magazine 100 Award

Published: Monday, July 09, 2012
Last Updated: Monday, July 09, 2012
Bookmark and Share
Samplicity® Filtration System recognized as one of the 100 most technologically significant products introduced into marketplace.

EMD Millipore, the Life Science division of Merck KGaA announces it has received the R&D Magazine 100 Award for its product, the Samplicity® Filtration system.

The Samplicity® Filtration system provides a higher throughput, ergonomic alternative to syringe-tip filters for the preparation of liquid chromatography samples. The Samplicity® filtration system is utilized in research and development laboratories testing drug dissolution, food safety, cosmetics, biofuels and pharmacokinetic and pharmacodynamic properties of drugs.

“We are proud to have won the prestigious R&D Magazine 100 Award for our Samplicity® filtration system,” says John Sweeney, Head, Bioscience Business Unit, EMD Millipore. “This recognition is a testament to our commitment to offer our customers breakthrough technologies they can use to keep up with rapid advances in life science. With the Samplicity® system, which enables customers to prepare samples more efficiently and with higher recovery, we’ve met the demands of today’s ultra-fast, ultra-sensitive chromatographic analyses.”

The Samplicity® filtration system is the first vacuum-driven device with the flexibility to filter 1 to 8 samples in seconds, including samples with high viscosity or high particulate levels. In addition, the system has a low hold-up volume, which allows processing of samples as small as 300 μL with high recovery.

The R&D 100 Awards have long been a benchmark of excellence for industry sectors as diverse as telecommunications, high-energy physics, software, manufacturing, and biotechnology. The winners represent a cross-section of industry, academia, private research firms, and government labs. Winning technologies are used in medical, industrial, research, consumer, and manufacturing applications.

Since 1963, the R&D 100 Awards have identified revolutionary technologies newly introduced to the market. Many of these have become household names, helping shape everyday life for many Americans. These include the flashcube (1965), the automated teller machine (1973), the halogen lamp (1974), the fax machine (1975), the liquid crystal display (1980), the Kodak Photo CD (1991), the Nicoderm anti-smoking patch (1992), Taxol anticancer drug (1993), lab on a chip (1996), and HDTV (1998).

Winners of the R&D 100 Awards are selected by an independent judging panel and the editors of R&D Magazine.

The Samplicity® filtration system received the Editor’s Silver Award for best new product at Pittcon 2011.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Cell Transplant Treats Parkinson’s in Mice
A University of Wisconsin—Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell.
Understanding Female HIV Transmission
Glowing virus maps points of entry through entire female reproductive tract for first time.
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
Common Class of Cancer Drugs May Not Lead to Cognitive Decline
UCLA study refutes 2015 research suggesting anthracyclines could cause memory loss, other impairments.
Designing Better Drugs
A rational drug engineering approach could breathe new life into drug development.
Genetic Approach May Lead to New Treatments for Digestive Diseases
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
Potential Target for Revolutionary Antibiotics
An international team of including the Lomonosov Moscow State University researchers discovered which enzyme enables Escherichia coli bacterium (E. coli) to breathe.
Unique Model for Studying ALS
Unique mouse model will allow researchers to better study the genetic origins and potential treatments of ALS.
Factors Influencing Influenza Vaccine Effectiveness Uncovered
The long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited, new research suggests.
New Model to Enhance Zika Virus Research
The model will allow researchers to better understand how the virus causes disease and aid in the development of antiviral compounds and vaccines.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!